Allgens Medical Technology CO., LTD. (SHA:688613)

SHA:688613 Balance Sheet

Financials in millions CNY. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Sep 30, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Cash & Equivalents	137.94	156.71	161.25	259.87	411.31	21.12
Short-Term Investments	-	-	27.74	-	-	-
Trading Asset Securities	910.44	895.57	902.18	816.08	653.88	470.7
Cash & Short-Term Investments	1,048	1,052	1,091	1,076	1,065	491.81
Cash Growth	-0.89%	-3.56%	1.42%	1.01%	116.58%	8.16%
Accounts Receivable	57.56	67.16	59.27	38.88	27.85	18.55
Other Receivables	13.87	13.75	9.47	1.04	4.05	13.8
Receivables	71.43	80.91	68.74	39.92	31.9	32.35
Inventory	85.6	54.58	32.7	18.31	19.03	21.91
Prepaid Expenses	-	-	-	0.1	0.66	1.97
Other Current Assets	9.63	8.62	8.13	8.06	4.11	6.44
Total Current Assets	1,215	1,196	1,201	1,142	1,121	554.48
Property, Plant & Equipment	170.58	180.57	186.57	188.82	195.53	205.63
Goodwill	24.62	24.62	-	-	-	-
Other Intangible Assets	23.98	25.36	22.06	23.36	24.63	25.84
Long-Term Deferred Tax Assets	23.84	23.84	21.73	18.59	14.18	10.34
Long-Term Deferred Charges	29.64	35.49	34.66	21.64	4.32	6.34
Other Long-Term Assets	57.13	52.88	60.49	64.45	66.54	2.3
Total Assets	1,545	1,539	1,526	1,459	1,426	804.93
Accounts Payable	15.63	12.95	10.39	7.38	3.3	1.07
Accrued Expenses	4.61	19.18	12.96	12.57	17.52	8.14
Short-Term Debt	-	-	-	-	-	20
Current Portion of Long-Term Debt	35.9	4.6	4.1	10.67	8.68	-
Current Portion of Leases	-	2.02	0.97	5.01	10.44	-
Current Income Taxes Payable	3.59	4.44	-	2.72	1.18	11.54
Current Unearned Revenue	5.56	5.11	10.23	4.02	2.94	1.21
Other Current Liabilities	2.65	3.97	12.15	6.09	11.12	29.43
Total Current Liabilities	67.94	52.26	50.79	48.46	55.18	71.39
Long-Term Debt	6.5	40.75	45.35	45.9	56.5	49.47
Long-Term Leases	0.84	4.98	3	-	5.01	-
Long-Term Unearned Revenue	20.48	20.94	22.19	34.94	36.19	31.93
Long-Term Deferred Tax Liabilities	0.29	0.26	1.28	4.2	2.61	0.45
Total Liabilities	96.06	119.2	122.61	133.5	155.49	153.25
Common Stock	137.01	135.55	133.33	133.33	133.33	100
Additional Paid-In Capital	982.58	966.59	926.92	887.73	887.73	420.25
Retained Earnings	314.97	301.03	321.82	281.63	222.68	101.9
Comprehensive Income & Other	0.48	-0.29	-	0.23	0.53	0.52
Total Common Equity	1,435	1,403	1,382	1,303	1,244	622.67
Minority Interest	13.74	17.09	21.57	22.79	26.31	29.02
Shareholders' Equity	1,449	1,420	1,404	1,326	1,271	651.68
Total Liabilities & Equity	1,545	1,539	1,526	1,459	1,426	804.93
Total Debt	43.24	52.35	53.42	61.59	80.63	69.47
Net Cash (Debt)	1,005	999.93	1,038	1,014	984.56	422.34
Net Cash Growth	-0.30%	-3.65%	2.31%	3.03%	133.12%	8.77%
Net Cash Per Share	6.54	7.11	7.85	7.56	8.23	4.23
Filing Date Shares Outstanding	137.01	135.55	133.33	133.33	133.33	100
Total Common Shares Outstanding	137.01	135.55	133.33	133.33	133.33	100
Working Capital	1,147	1,144	1,150	1,094	1,066	483.08
Book Value Per Share	10.47	10.35	10.37	9.77	9.33	6.23
Tangible Book Value	1,386	1,353	1,360	1,280	1,220	596.83
Tangible Book Value Per Share	10.12	9.98	10.20	9.60	9.15	5.97
Buildings	-	190.14	187.21	185.69	117.45	68.25
Machinery	-	63.64	60.14	31.14	32.26	32.23
Construction In Progress	-	0.07	0.33	1.47	60.85	138.97

Source: S&P Global Market Intelligence. Standard template. Financial Sources.